Montagu Private Equity announces the sale of VetXX
Summary
Montagu Private Equity is selling VetXX to Dechra Pharmaceuticals. VetXX develops, produces, and markets companion animal veterinary products and holds niche pharmaceutical licenses. Dechra says the deal will expand its European footprint, broaden its licensed product range, and strengthen its distribution network. The transaction is expected to close in January 2008, pending shareholder approval. This deal creates a larger veterinary products platform with more room for product and system integration.
Classifications
industries
Fintech & Banking
applications
ERP & Process Management
AskAI Classifications
Labels
Enterprise Software
SaaS
Risk Management Software
Linked Companies
PwC
$1B+